Date
December 8, 2022
Venue
The University of Tokyo
Capacity
60+ People
INTRODUCTION
TECRO Science and Technology Division in Japan will jointly organize a hybrid (on-site and online) Biomedical Technology Workshop "2022 Japan-Taiwan Precision Medicine, Biomedical Technology and Smart Services Workshop" on December 8 in conjunction with the Taiwan Science and Technology Association(台灣科學技術協會) and the University of Tokyo ". This event will invite experts from industry and academia in the field of Biomedical technology from Japan and Taiwan. During the Workshop, the development status and future direction of biotech will be introduced. This advanced topic is expected to attract the participation of professionals and scientific research students in various fields, and to achieve the function of professional exchange and popular science education.
Organizers
Organizer & Moderator
Wei-Lun HSU
Lecturer, Department of Mechanical Engineering,
Graduate School of Engineering,
The University of Tokyo
Yu-Han TSOU
Senior Advisor, Taipei Economic and Cultural Representative Office in Japan;
General Director, Science and Technology Division, National Science and Technology Council (NSTC)
Distinguished Professor, Fu Jen Catholic University in Taiwan
Organizer
Ginsuke KONO
President, Taiwan Science and Technology Association
Professor, Kisarazu National College of Technology
Speakers
Opening Remark
Frank C.T. HSIEH
Representative, Taipei Economic and Cultural Representative Office in Japan
Kenichi FUJITA
Director, International Affairs Division, RIKEN
Chikashi NAKAMURA
Director, International Affairs Office,
Planning Headquarters, AIST
Shu TAKAGI
Head of Department (Professor), Department of Mechanical Engineering, Graduate School of Engineering, The University of Tokyo
Professor, Department of Bioengineering, School of Engineering, The University of Tokyo
Ginsuke KONO
President, Taiwan Science and Technology Association
Professor, Kisarazu National College of Technology
Keynote Speech
Hidehiro OANA
Associate Professor, The University of Tokyo
Wei-Lun HSU
Lecturer, Department of Mechanical Engineering, Graduate School of Engineering, The University of Tokyo
Kenichi FUJITA
Director, International Affairs Division, RIKEN
Margaret Dah-Tsyr CHANG
Chief Strategy Officer
JelloX Biotech Inc.
Shinji SUGIURA
Deputy Leader, AIST-INDIA Diverse Assets and Applications International Laboratory
Hiroyuki SUZUKI
Executive Vice President, Representative Director
Advanced Telecommunications Research Institute International (ATR)
Kevin CHAO
Chief Strategy Officer
CancerFree Biotech
Time Schedule
Time :December 8 2022
Venue : 31A, Faulculty of Engineering Building 2, Hongo Campus, the University of Tokyo
Webex: LINK
| Date and Time (JST time) |
Speaker | ||
|---|---|---|---|
| December 8 2022 8:50-9:00 (10 min) | Check-in and registration at venue/Login online | ||
| Opening Remark Moderator: Dr. Yu-Han Tsou, TECRO | |||
| December 8 2022 9:00-9:30 (30 min) | TECRO-JP (3~5min) | Representative Frank C.T. Hsieh | |
| RIKEN (3~5min) | Dr. Kenichi Fujita | ||
| AIST (3~5min) | Dr. Chikashi Nakamura | ||
| Univ. Tokyo (3~5min) | Dr. Shu Takagi | ||
| 台湾科学技術協会(3~5min) | Dr. Ginsuke Kouno | ||
| Short break/photo | |||
| Keynote Speech Moderator: Dr. Wei-Lun Hsu | |||
| December 8 2022 9:30-11:10 (100 min) | |||
| Univ. Tokyo (20 min) | Dr. Hidehiro Oana Title: A Microfluidic Device for Direct Observation-based Single Cell Epigenetic Analysis |
||
| Univ. Tokyo (20 min) | Dr. Wei-Lun Hsu Title: Solid-state Nanopore Technology: Challenges and Opportunities |
||
| RIKEN (20 min) | Dr. Kenichi Fujita Title: Biological Research in RIKEN |
||
| JelloX Biotech Inc. (20 min) | Dr. Dah-Tsyr Chang Title: Next Generation Pathology Integrating 3D Imaging and AI Analyses for Precision Medicine |
||
| Q＆A(5 min) | |||
| Short break(10 min) | |||
| December 8 2022 11:10-12:20 (70 min) | |||
| AIST (20 min) | Dr. Shinji Sugiura Title: Development of a pneumatic pressure-driven microphysiological systems |
||
| ATR (20 min) | Dr. Hiroyuki Suzuki Title:Collaborations between Japan and Taiwan from Science to Innovation |
||
| CancerFree Biotech(20min) | Mr. Kevin Chao Title: Avatar Medicine – redefining personalized precision medicine |
||
| Q＆A(5 min) | |||
| Closing(12:20-12:30) | |||
Registration
Sponsors
